Table 2.

Clinical outcomes at 30 days and 2 years with or without CAD.

Outcome	30 days		p–Value*	2 years		p-Value*
	CAD n = 46	Non-CAD n = 45		CAD n = 46	Non-CAD n = 45
	No of patients (%)			No of patients (%)
Death from all causes	4 (9)	2 (5)	0.446	17 (50)	9 (24)	0.042
Death from cardiovascular causes	2 (3)	1 (3)	0.890	10 (35)	3 (8)	0.038
Stroke or TIA	5 (11)	3 (7)	0.520	9 (20)	5 (15)	0.321
Myocardial infarction	0	0		1 (2)	0	0.160
Major vascular complications	5 (11)	4 (10)	0.441	6 (12)	4 (10)	0.448
Major bleeding	5 (11)	4 (10)	0.441	6 (12)	4 (10)	0.448
Acute renal lesion	6 (13)	4 (10)	0.580	7 (14)	5 (11)	0.652
NOAF	11 (30)	8 (20)	0.621	11 (30)	9 (23)	0.601
New pacemaker implantation	16 (34)	12 (27)	0.442	16 (34)	12 (27)	0.458

All percentages are Kaplan–Meier estimates at the specific time point and thus do not equal the number of patients divided by the total of number in the study group. CAD, coronary artery disease; NOAF, new onset atrial fibrillation; TIA, transient ischemic attack.

*p-Values are for the between-group comparison of the frequency of the event at each time point.